tiprankstipranks

Heath Lukatch Insider Profile

11 Followers
Heath Lukatch, Director at Flexion Therapeutics, holds 5.63K shares in Vaxcyte (Ticker: PCVX), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN), holds ― shares in Satsuma Pharmaceuticals (Ticker: STSA).
tipranks
Heath Lukatch

Heath Lukatch
Flexion Therapeutics (FLXN)
Director

Ranked #61,772 out of 97,825 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-8.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$487K
79.11%
20.89%
A breakdown of Heath Lukatch's holdings

Insider Roles

Vaxcyte
(PCVX)
Director
Inogen
(INGN)
Director
Roles that Heath Lukatch holds in companies

Most Profitable Insider Trade

Stock:
Inogen
(INGN)
Rating:Informative Sell
Date:Aug 08, 2018 - Aug 08, 2019
Return:+79.70%
The most profitable trade made by Heath Lukatch

Heath Lukatch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FLXN
Flexion Therapeutics
Nov 19, 2021
Uninformative Sell
76.50K
$0.00
Vaxcyte
Feb 02, 2024
Director
Uninformative Sell
357.50K
$385.31K
STSA
Satsuma Pharmaceuticals
Inogen
May 12, 2021
Director
Uninformative Buy
$101.75K
List of latest transactions for each holding click on a transaction to see Heath Lukatch's performance on stock

Heath Lukatch insider profile FAQ

What is the percentage of profitable transactions made by Heath Lukatch?
The percentage of profitable transactions made by Heath Lukatch is 50%.
    What is the average return per transaction made by Heath Lukatch?
    The average return per transaction made by Heath Lukatch is -8.30%.
      What stocks does Heath Lukatch hold?
      Heath Lukatch holds: FLXN, PCVX, STSA, INGN stocks.
        What was Heath Lukatch’s latest transaction?
        Heath Lukatch latest transaction was an Uninformative Sell of $357.50K.
          What was Heath Lukatch's most profitable transaction?
          Heath Lukatch’s most profitable transaction was an Informative Sell of INGN stock on August 8, 2018. The return on the trade was 79.70%.
            What is Heath Lukatch's role in Flexion Therapeutics?
            Heath Lukatch's role in Flexion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.